PMA P210036S009

Device
PerClot® Polysaccharide Hemostatic System
Applicant
Baxter Healthcare Corporation
PMA number
P210036
Supplement
S009
Product code
LMG
Decision date
2026-08-07
Classification
General, Plastic Surgery
Generic name
Agent, absorbable hemostatic, non-collagen based
Approval order statement
starch drying temperature and equipment modifications of the PerClot® Polysaccharide Hemostatic System

Current openFDA PMA Record#

Device
PerClot® Polysaccharide Hemostatic System
Applicant
Baxter Healthcare Corporation
PMA number
P210036
Supplement
S009
Product code
LMG
Generic name
Agent, absorbable hemostatic, non-collagen based
Decision date
2026-08-07
Decision code
APPR
Date received
2026-03-09
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
starch drying temperature and equipment modifications of the PerClot® Polysaccharide Hemostatic System